ALLOFLO™ UVEO Clinical Evidence

The Crest Study

One of the largest prospective cohorts in interventional glaucoma.
>450
eyes enrolled
16
locations
2+
years
4 PEER-REVIEWED PUBLICATIONS
117 eyes at 12 months 2

SAFETY &
EFFICACY
31 eyes at 24 months 4

SAFETY &
EFFICACY
243 eyes at 24 months 4

POST-OP SAFETY ANALYSIS
51 medically uncontrolled eyes at 12 months 2

SAFETY &
EFFICACY

Traditional
CycloDIALYSIS

The ability for cyclodialysis to significantly reduce IOP has beenunderstood for over 100 years.
Meta-analysis of 40 evidence-based studies: 1
More than 4,000  eyes
Data collected over a 100-year period
Up to 10 years of follow-up
Demonstrated average success rate comparable to MIGS

*Across all studies, the average qualified success rate was 72.3% (range: 33-97%) over follow-up periods of 6 to 132 months.
EFFICACY OF BIO-REINFORCED CYCLODIALYSIS
Minimally invasive with improved precision & reproducibility of cyclodialysis creation and patency.
32-40%
MEAN IOP REDUCTION 2-5
12-24 month
40-64%
MEAN MEDICATION REDUCTION 2-5
12-24 month
*Across all studies, the average qualified success rate was 72.3% (range: 33-97%) over follow-up periods of 6 to 132 months.
SAFETY PROFILE OF BIO-REINFORCED CYCLODIALYSIS
A clinically-validated bio-interventional approach.
243 eyes
Timeframe
Percent of eyes
Clinical Hypotony3
≥ 30 days
< 0.5%
Elivated IOP**3
At/after 1 month post-op
< 5%
** Procedure related, >30 mmHg or +10 mmHg from baseline
31 eyes
Timeframe
Mean ECL
Endothelial Cell Loss4
24 months
< 10%†
† Consistent with expected loss seen after cataract and microinvasive glaucoma surgery (MIGS) procedures. No eyes had significant (>30%) endothelial cell loss.
243 eyes
Timeframe
Percent of eyes
Clinical Hypotony3
≥ 30 days
< 0.5%
Elavated IOP**3
At/after 1 month post-op
< 0.5%
31 eyes
Timeframe
Main ECL
Endothelial Cell Loss4
24 months
< 10%†

Real-world Application

Bio-intervention with AlloFloTM Uveo
3,000+
CASES 6
100+
U.S. SURGEONS 6
Contributors
PEER-REVIEWED PUBLICATIONS
Lautaro Vera, MD
Robert Weinreb, MD
Ticiana De Francesco, MD
Arsham Sheybani, MD
Nate Radcliffe, MD
Michael Patterson, DO
Leon Herndon, MD
Kevin Barber, MD
Gautam Kamthan, MD
Jorge Lince, MD
Douglas Rhee, MD
Ernesto Calvo, MD
Arkadiy Yadgarov, MD
Ehsan Sadri, MD
Craig Chaya, MD
Brian Flowers, MD
THE CREST STUDY
Lautaro Vera, MD
Won Kim, MD
Toby Tyson, MD
Stephen Smith, MD
Reena Garg, MD
James Lewis, MD
Gabriel Ferreira, MD
Eva Liang, MD
Ehsan Sadri, MD
Rajen Desai, MD
Deepan Selvadurai, MD
Craig Chaya, MD
Brian Flowers, MD
Arian Moses, MD

Surgical Videos

To gain access, enter your 10-digit Provider NPI number:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Submit
PRESENTATION LIBRARY
Clinical Webinar, Oct 8, 2025: Radcliffe, Sheybani, Provencher
Dr. Weinreb Unveils New Supraciliary Bio-Stenting MIGS